These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3316389)

  • 1. Differential expression of the c-myb proto-oncogene marks the pre-B cell/B cell junction in murine B lymphoid tumors.
    Bender TP; Kuehl WM
    J Immunol; 1987 Dec; 139(11):3822-7. PubMed ID: 3316389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constitutive versus cell cycle regulation of c-myb mRNA expression correlates with developmental stages in murine B lymphoid tumors.
    Catron KM; Purkerson JM; Isakson PC; Bender TP
    J Immunol; 1992 Feb; 148(3):934-42. PubMed ID: 1730880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The A-myb gene is preferentially expressed in tonsillar CD38+, CD39-, and sIgM- B lymphocytes and in Burkitt's lymphoma cell lines.
    Golay J; Erba E; Bernasconi S; Peri G; Introna M
    J Immunol; 1994 Jul; 153(2):543-53. PubMed ID: 8021494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of membrane and secreted immunoglobulin during the in vitro differentiation of the murine B cell lymphoma CH12.
    Stockdale AM; Dul JL; Wiest DL; Digel M; Argon Y
    J Immunol; 1987 Nov; 139(10):3527-35. PubMed ID: 3500220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deregulated c-Myb expression in murine myeloid leukemias prevents the up-regulation of p15(INK4b) normally associated with differentiation.
    Schmidt M; Koller R; Haviernik P; Bies J; Maciag K; Wolff L
    Oncogene; 2001 Sep; 20(43):6205-14. PubMed ID: 11593429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of c-myb gene regulation in MRL-lpr/lpr mice. Identification of a 5' c-myb nuclear protein binding site and high levels of binding factors in nuclear extracts of lpr/lpr lymph node cells.
    Mountz JD; Steinberg AD
    J Immunol; 1989 Jan; 142(1):328-35. PubMed ID: 2642505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microsatellite deletions in the c-myb transcriptional attenuator region associated with over-expression in colon tumour cell lines.
    Thompson MA; Flegg R; Westin EH; Ramsay RG
    Oncogene; 1997 Apr; 14(14):1715-23. PubMed ID: 9135073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of the c-myb, c-myc and p53 mRNA and protein levels during induced murine erythroleukemia cell differentiation.
    Richon VM; Ramsay RG; Rifkind RA; Marks PA
    Oncogene; 1989 Feb; 4(2):165-73. PubMed ID: 2648254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posttranscriptional regulation of the c-myb proto-oncogene in estrogen receptor-positive breast cancer cells.
    Gudas JM; Klein RC; Oka M; Cowan KH
    Clin Cancer Res; 1995 Feb; 1(2):235-43. PubMed ID: 9815978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogene expression in autoimmune mice.
    Mountz JD; Mushinski JF; Mark GE; Steinberg AD
    J Mol Cell Immunol; 1985; 2(3):121-31. PubMed ID: 3916923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-CD20- and B-cell receptor-mediated apoptosis: evidence for shared intracellular signaling pathways.
    Mathas S; Rickers A; Bommert K; Dörken B; Mapara MY
    Cancer Res; 2000 Dec; 60(24):7170-6. PubMed ID: 11156427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of oncogenes in normal and transformed murine B lymphocytes.
    DeCino P; Lernhardt W; Herbst H; Raschke WC
    Oncogene Res; 1988; 3(1):33-7. PubMed ID: 3264606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-Myb prevents growth arrest associated with terminal differentiation of monocytic cells.
    Bies J; Hoffman B; Amanullah A; Giese T; Wolff L
    Oncogene; 1996 Jan; 12(2):355-63. PubMed ID: 8570212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of a c-Myb/estrogen receptor fusion protein in transformed primary cells leads to granulocyte/macrophage differentiation and down regulation of c-kit but not c-myc or cdc2.
    Hogg A; Schirm S; Nakagoshi H; Bartley P; Ishii S; Bishop JM; Gonda TJ
    Oncogene; 1997 Dec; 15(24):2885-98. PubMed ID: 9416832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted disruption of c-myb in the chicken pre B-cell line DT40.
    Appl H; Klempnauer KH
    Oncogene; 2002 May; 21(19):3076-81. PubMed ID: 12082539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal patterns of A-myb and B-myb gene expression during testis development.
    Latham KE; Litvin J; Orth JM; Patel B; Mettus R; Reddy EP
    Oncogene; 1996 Sep; 13(6):1161-8. PubMed ID: 8808690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of B cell-associated transcription factors in B-cell precursor acute lymphoblastic leukemia cells: association with PU.1 expression, phenotype, and immunogenotype.
    Nishii K; Kita K; Miwa H; Shikami M; Taniguchi M; Usui E; Katayama N; Shiku H
    Int J Hematol; 2000 Jun; 71(4):372-8. PubMed ID: 10905058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colonic expression of c-myb is initiated in utero and continues throughout adult life.
    Rosenthal MA; Thompson MA; Ellis S; Whitehead RH; Ramsay RG
    Cell Growth Differ; 1996 Jul; 7(7):961-7. PubMed ID: 8809414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
    Suhasini M; Boss GR; Pascual FE; Pilz RB
    Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the c-myb proto-oncogene during cellular proliferation.
    Thompson CB; Challoner PB; Neiman PE; Groudine M
    Nature; 1986 Jan 30-Feb 5; 319(6052):374-80. PubMed ID: 3511387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.